HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Sun Pharma’s arm recalls 9,840 bottles of Morphine Sulfate extended-release tablets in US
Mar-17-2025

Sun Pharmaceutical Industries’ subsidiary -- Sun Pharmaceutical Industries Inc. is recalling 9,840 bottles of Morphine Sulfate extended-release tablets in the US market for ‘Failed Dissolution Specifications’. The company initiated the Class II nationwide (US) recall on February 6, 2025.

As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


  RELATED NEWS >>